Lanean...
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors
BACKGROUND: Breast cancer tumors are known to be highly heterogeneous and differences in their metabolic phenotypes, especially at protein level, are less well-understood. Profiling of metabolism-related proteins harbors the potential to establish new patient stratification regimes and biomarkers pr...
Gorde:
| Argitaratua izan da: | Breast Cancer Res |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5637318/ https://ncbi.nlm.nih.gov/pubmed/29020998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-017-0905-7 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|